FDA.reportPublic FDA data

C1 esterase inhibitor (human) 500 UNT Injection [Cinryze]

RxCUI
809871
RxNorm name
C1 esterase inhibitor (human) 500 UNT Injection [Cinryze]
Display name
C1 esterase inhibitor (human) 500 UNT Injection [Cinryze]
Full name
C1 esterase inhibitor (human) 500 UNT Injection [Cinryze]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125267CinryzeC1 Esterase Inhibitor (Human)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d53a911f-070d-498a-8a61-baab72b9d0feCinryze 500 UNT Injection [PSN] · C1 esterase inhibitor (human) 500 UNT Injection [Cinryze] [SBD] · Cinryze 500 UNT Injection [SY]342These highlights do not include all the information needed to use CINRYZE ® safely and effectively. See full prescribing information for CINRYZE. CINRYZE (C1 esterase inhibitor [human]) for intravenous use, freeze-dried powder for reconstitution Initial U.S. Approval: 2008.20251128